Concord Biotech Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Mangalore Refinery And Petrochemicals Ltd, Cartrade Tech Ltd, IFCI Ltd, RHI Magnesita India Ltd are among the other stocks to see a surge in volumes on NSE today, 03 June 2026.

Concord Biotech Ltd notched up volume of 53.35 lakh shares by 14:14 IST on NSE, a 14.12 fold spurt over two-week average daily volume of 3.78 lakh shares. The stock rose 3.74% to Rs.1,209.80. Volumes stood at 18.58 lakh shares in the last session.

Mangalore Refinery And Petrochemicals Ltd witnessed volume of 225.12 lakh shares by 14:14 IST on NSE, a 7.07 times surge over two-week average daily volume of 31.86 lakh shares. The stock increased 4.34% to Rs.153.40. Volumes stood at 28.97 lakh shares in the last session.

Cartrade Tech Ltd notched up volume of 26.83 lakh shares by 14:14 IST on NSE, a 5.18 fold spurt over two-week average daily volume of 5.18 lakh shares. The stock rose 8.55% to Rs.1,948.40. Volumes stood at 3.79 lakh shares in the last session.

IFCI Ltd recorded volume of 2229.96 lakh shares by 14:14 IST on NSE, a 5.14 times surge over two-week average daily volume of 433.75 lakh shares. The stock gained 12.83% to Rs.80.83. Volumes stood at 1057.43 lakh shares in the last session.

RHI Magnesita India Ltd recorded volume of 60.27 lakh shares by 14:14 IST on NSE, a 5.08 times surge over two-week average daily volume of 11.88 lakh shares. The stock gained 8.95% to Rs.375.50. Volumes stood at 29.11 lakh shares in the last session.

Powered by Capital Market - Live News

Divis Laboratories Ltd, Granules India Ltd, Mangalore Refinery And Petrochemicals Ltd, Alkyl Amines Chemicals Ltd are among the other stocks to see a surge in volumes on BSE today, 03 June 2026.

Concord Biotech Ltd witnessed volume of 1.68 lakh shares by 10:46 IST on BSE, a 9.35 times surge over two-week average daily volume of 17948 shares. The stock increased 6.13% to Rs.1,238.30. Volumes stood at 74467 shares in the last session.

Divis Laboratories Ltd saw volume of 1.78 lakh shares by 10:46 IST on BSE, a 7.15 fold spurt over two-week average daily volume of 24834 shares. The stock dropped 0.15% to Rs.6,518.50. Volumes stood at 16261 shares in the last session.

Granules India Ltd clocked volume of 5.05 lakh shares by 10:46 IST on BSE, a 4.59 times surge over two-week average daily volume of 1.10 lakh shares. The stock gained 1.71% to Rs.790.10. Volumes stood at 30974 shares in the last session.

Mangalore Refinery And Petrochemicals Ltd registered volume of 8.35 lakh shares by 10:46 IST on BSE, a 3.76 fold spurt over two-week average daily volume of 2.22 lakh shares. The stock rose 4.11% to Rs.153.25. Volumes stood at 1.53 lakh shares in the last session.

Alkyl Amines Chemicals Ltd witnessed volume of 48669 shares by 10:46 IST on BSE, a 3.25 times surge over two-week average daily volume of 14986 shares. The stock increased 1.11% to Rs.1,806.40. Volumes stood at 84431 shares in the last session.

Powered by Capital Market - Live News

Mycophenolate mofetil is an antimetabolite immunosuppressant used to prevent organ rejection in adult and pediatric patients aged three months and older who have undergone kidney, heart, or liver transplants, in combination with other immunosuppressants.

According to market estimates, the U.S. market for Mycophenolate Mofetil is approximately US$ 30 million. The approval positions the company to capitalize on these attractive market opportunities, enhance its product offerings, and support its long-term growth strategy across the U.S. and international markets.

Concord Biotech is a R&D driven biopharma company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. It has a presence in more than 70 countries worldwide.

The company?s consolidated net profit declined 36.75% to Rs 88.79 crore on 24.15% drop in revenue frm operations to Rs 326.07 crore in Q4 FY26 over Q4 FY25

Powered by Capital Market - Live News

Concord Biotech has received approval from the U.S. Food and Drug Administration (USFDA) for its ANDA for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL. Mycophenolate mofetil is an antimetabolite immunosuppressant indicated for the prophylaxis of organ rejection in adult and pediatric recipients 3 months of age and older of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants.